Baugh & Associates, LLC Pfizer Inc Transaction History

Baugh & Associates, LLC

  • $199 Million
  • Q3 2024

A detailed history of Baugh & Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Baugh & Associates, LLC holds 165,143 shares of PFE stock, worth $4.33 Million. This represents 2.4% of its overall portfolio holdings.

Number of Shares
165,143
Previous 164,146 0.61%
Holding current value
$4.33 Million
Previous $4.59 Million 4.07%
% of portfolio
2.4%
Previous 2.51%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$27.7 - $31.39 $27,616 - $31,295
997 Added 0.61%
165,143 $4.78 Million
Q2 2024

Jul 12, 2024
SELL
$25.26 - $29.6 $185,913 - $217,856
-7,360 Reduced 4.29%
164,146 $4.59 Million
Q1 2024

Apr 15, 2024
BUY
$25.89 - $29.73 $1.14 Million - $1.31 Million
43,907 Added 34.41%
171,506 $4.76 Million
Q4 2023

Jan 10, 2024
SELL
$26.13 - $33.94 $151,893 - $197,293
-5,813 Reduced 4.36%
127,599 $3.67 Million
Q3 2023

Oct 13, 2023
BUY
$32.09 - $37.51 $620,075 - $724,805
19,323 Added 16.94%
133,412 $4.43 Million
Q2 2023

Jul 20, 2023
BUY
$36.12 - $41.79 $68,266 - $78,983
1,890 Added 1.68%
114,089 $4.18 Million
Q1 2023

Apr 27, 2023
SELL
$39.39 - $51.28 $89,415 - $116,405
-2,270 Reduced 1.98%
112,199 $4.58 Million
Q4 2022

Jan 27, 2023
SELL
$41.75 - $54.5 $5,010 - $6,540
-120 Reduced 0.1%
114,469 $0
Q3 2022

Oct 07, 2022
BUY
$43.76 - $53.42 $67,302 - $82,159
1,538 Added 1.36%
114,589 $5.01 Million
Q2 2022

Jul 19, 2022
SELL
$46.53 - $55.17 $55,324 - $65,597
-1,189 Reduced 1.04%
113,051 $5.93 Million
Q1 2022

Apr 20, 2022
SELL
$45.75 - $56.69 $16,241 - $20,124
-355 Reduced 0.31%
114,240 $5.91 Million
Q4 2021

Jan 14, 2022
SELL
$41.32 - $61.25 $3,512 - $5,206
-85 Reduced 0.07%
114,595 $6.77 Million
Q3 2021

Oct 13, 2021
SELL
$39.25 - $50.42 $7,339 - $9,428
-187 Reduced 0.16%
114,680 $4.93 Million
Q2 2021

Jul 12, 2021
SELL
$35.91 - $40.68 $35,910 - $40,680
-1,000 Reduced 0.86%
114,867 $4.5 Million
Q1 2021

Apr 16, 2021
BUY
$33.49 - $37.77 $415,912 - $469,065
12,419 Added 12.01%
115,867 $4.2 Million
Q4 2020

Jan 13, 2021
BUY
$33.47 - $42.56 $119,688 - $152,194
3,576 Added 3.58%
103,448 $3.81 Million
Q3 2020

Oct 28, 2020
SELL
$31.75 - $37.25 $47,307 - $55,502
-1,490 Reduced 1.47%
99,872 $3.67 Million
Q2 2020

Jul 09, 2020
BUY
$30.12 - $36.54 $89,908 - $109,071
2,985 Added 3.03%
101,362 $3.32 Million
Q1 2020

Apr 21, 2020
SELL
$27.03 - $38.62 $44,977 - $64,263
-1,664 Reduced 1.66%
98,377 $3.21 Million
Q4 2019

Jan 13, 2020
BUY
$32.92 - $37.36 $108,504 - $123,138
3,296 Added 3.41%
100,041 $3.92 Million
Q3 2019

Oct 08, 2019
BUY
$32.49 - $42.13 $138,342 - $179,389
4,258 Added 4.6%
96,745 $3.48 Million
Q2 2019

Jul 23, 2019
SELL
$36.98 - $41.52 $79,691 - $89,475
-2,155 Reduced 2.28%
92,487 $4.01 Million
Q1 2019

Apr 05, 2019
SELL
$37.5 - $41.2 $26,025 - $28,592
-694 Reduced 0.73%
94,642 $4.02 Million
Q4 2018

Jan 17, 2019
SELL
$38.47 - $43.86 $15,618 - $17,807
-406 Reduced 0.42%
95,336 $4.16 Million
Q3 2018

Nov 02, 2018
BUY
$34.47 - $41.81 $27,920 - $33,866
810 Added 0.85%
95,742 $4.22 Million
Q2 2018

Jul 27, 2018
SELL
$32.98 - $35.16 $259,750 - $276,920
-7,876 Reduced 7.66%
94,932 $3.44 Million
Q1 2018

Apr 25, 2018
BUY
$31.91 - $37.02 $275,447 - $319,556
8,632 Added 9.17%
102,808 $3.65 Million
Q4 2017

Feb 08, 2018
BUY
$33.26 - $35.29 $3.13 Million - $3.32 Million
94,176
94,176 $3.41 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.73B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Baugh & Associates, LLC Portfolio

Follow Baugh & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baugh & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baugh & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email